Introgen Therapeutics Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

ViRexx Medical Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Aphton Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Medimmune Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Bionumerik Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Gamida-Cell Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Onyvax Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Clavis Pharma Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Protherics Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Glycogenesys Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Aeterna Zentaris Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Isis Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Viventia Biotech Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Ariad Pharmaceuticals Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Celgene Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005

Meditech Research Cancer Company Intelligence Report Espicom publishes over 135 reports on companies developing anti-cancer drugs from the largest blue-chip ...more

Market Briefing September 2005